A team has made a major breakthrough in the field of three-dimensional (3D) imaging of large-scale biological tissues. They developed the world's fastest high-definition 3D imaging technology for ...

(NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the closing of its acquisition of an intellectual ...

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the ...